MET Expressed in Glioma Stem Cells Is a Potent Therapeutic Target for Glioblastoma Multiforme.

MLA

Tasaki, Takayuki, et al. “MET Expressed in Glioma Stem Cells Is a Potent Therapeutic Target for Glioblastoma Multiforme.” Anticancer Research, vol. 36, no. 7, July 2016, pp. 3571–77. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=27354625&authtype=sso&custid=ns315887.

APA

Tasaki, T., Fujita, M., Okuda, T., Yoneshige, A., Nakata, S., Yamashita, K., Yoshioka, H., Izumoto, S., & Kato, A. (2016). MET Expressed in Glioma Stem Cells Is a Potent Therapeutic Target for Glioblastoma Multiforme. Anticancer Research, 36(7), 3571–3577.

Chicago

Tasaki, Takayuki, Mitsugu Fujita, Takeshi Okuda, Azusa Yoneshige, Susumu Nakata, Kimihiro Yamashita, Hiromasa Yoshioka, Shuichi Izumoto, and Amami Kato. 2016. “MET Expressed in Glioma Stem Cells Is a Potent Therapeutic Target for Glioblastoma Multiforme.” Anticancer Research 36 (7): 3571–77. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=27354625&authtype=sso&custid=ns315887.